ライフサイエンスコーパス: leucocyte

1 elial cells), CD14 (monocytes) and CD45 (pan-leucocytes).

2 crease in sputum neutrophils and circulating leucocytes.

3 ely via its inhibitory effects on phagocytic leucocytes.

4 d to vascular endothelial cells and invading leucocytes.

5 sequently confirmed by enzyme measurement on leucocytes.

6 s differ quite radically from those in other leucocytes.

7 heir ability to bind and recruit circulating leucocytes.

8 y to induce migration of specific subsets of leucocytes.

9 lysis of reverse transcribed mRNA from blood leucocytes.

10 ve better imaging results than radiolabelled leucocytes.

11 howed the same Y-chromosome deletion seen in leucocytes.

12 otic niche and enhance the transmigration of leucocytes.

13 enol-soluble modulins (PSMs), by circulating leucocytes.

14 ion, and with elevated counts of circulating leucocytes.

15 kemia cells) and do not affect non-malignant leucocytes.

16 elial swelling with occasional intravascular leucocytes.

17 us-induced ER stress and type I IFN in human leucocytes.

18 erism of recipient-derived and donor-derived leucocytes.

19 WGS was performed in tumour and leucocytes.

20 odern studies on eosinophils and other blood leucocytes.

21 ined the PRLR sequence in 50 DNA samples (35 leucocytes, 15 tumors) from 46 prolactinoma patients (59

22 t included the presence of symptoms, urinary leucocytes, a positive urine culture, and symptom resolu

23 mopoietic cells, including immune-modulating leucocytes, a prerequisite of the tolerance induction st

24 About 25% of the generated leucocytes acquired MHC class II and costimulatory molec

25 ors play a key role in the transmigration of leucocytes across the blood-brain barrier (BBB).

26 y contribute to the increased trafficking of leucocytes across the blood-brain barrier as seen in cer

27 Leucocyte activation induces proteolytic shedding of L-s

28 c factors, since they are also implicated in leucocyte activation, angiogenesis, and antimicrobial fu

29 thelial Growth Factor Receptor-1(VEGF-1) and leucocyte activation/inflammation-Resistin, Neutrophil G

30 Regulation of leucocyte activity is crucial for a properly functioning

31 terized by reduced plasma leakage, decreased leucocyte adhesion and ameliorated lung pathology, culmi

32 Reducing leucocyte adhesion by inhibiting luminal VEGF signalling

33 ition of PATs attenuates barrier leakage and leucocyte adhesion induced by endothelial junction hyper

34 dep) display blunted barrier dysfunction and leucocyte adhesion, whereas leucocytes from these mice d

35 eutrophils are the most abundant circulating leucocytes and are essential for innate immunity.

36 xpression was significantly reduced in blood leucocytes and ASM obtained from patients with asthma co

37 hages that have engulfed erythrocytes and/or leucocytes and can harbour Salmonella in mice.

38 e detection of HHV-7 DNA in peripheral blood leucocytes and donorrecipient CMV serostatus.

39 Measurements included counts of leucocytes and its subtypes, as well as platelets.

40 ounts of emerin of normal size were found in leucocytes and lymphoblastoid cell lines.

41 Thanks to phagocytic leucocytes and other host defenses, the vast majority of

42 vascular endothelial cells, and circulating leucocytes and platelets.

43 hybrid cells following fusion between mobile leucocytes and proliferating tumour cells.

44 isease bound twice as many polymorphonuclear leucocytes and U937 cells as endothelial cells from unin

45 assessed HIMEC binding to polymorphonuclear leucocytes and U937 cells by means of an adhesion assay.

46 of the NK8(+) signature in peripheral blood leucocytes and validate their association with clinical

47 lood eosinophil count (<2% vs >/=2% of blood leucocytes) and whether or not patients had received inh

48 T cells, reduced MHC II expression on blood leucocytes, and a modest increase in bone marrow residen

49 890) and telomere length in peripheral blood leucocytes, and assessed their associations with chronic

50 re regulated general metabolism processes in leucocytes, and miRNA altered in remission are involved

51 current study was to investigate whether dog leucocyte antigen (DLA) class II alleles and haplotypes

52 Human leucocyte antigen (HLA) analysis in 11 patients showed a

53 Human leucocyte antigen (HLA) and trans-ancestry fine-mapping

54 ansplant in the UK are sensitised with human leucocyte antigen (HLA) antibodies.

55 4 and SACM2L) and a thus far unnoticed human leucocyte antigen (HLA) class II pseudogene, termed HLA-

56 cell exhaustion, and downregulation of human leucocyte antigen (HLA) class II.

57 A human leucocyte antigen (HLA) distribution analysis was also p

58 T-cells is influenced by the level of human leucocyte antigen (HLA) expression to determine hypersen

59 the strongest signal deriving from the human leucocyte antigen (HLA) gene HLA-DQA1.

60 Genetic variation at the Human Leucocyte Antigen (HLA) genes is associated with many au

61 that germline and somatic reduction of human leucocyte antigen (HLA) heterogeneity enhances the risk

62 genetic defect, which is linked to the human leucocyte antigen (HLA) locus.

63 s been active debate about the role of human leucocyte antigen (HLA) matching in kidney allograft sur

64 L2 receptor gamma chain knockout (NSG) human leucocyte antigen (HLA)-DQ8 transgenic animals.

65 to the Smith (Sm) autoantigen and the human leucocyte antigen (HLA)-DR15 haplotype; hence, we invest

66 ls were used to evaluate the effect of human leucocyte antigen (HLA)-DR2 (DRB1*1501, DQB1*0602) on cl

67 typically elderly men that often carry human leucocyte antigen (HLA)-DRB1*07:01 (~90%).

68 Human leucocyte antigen (HLA)-G, an immunosuppressive molecule

69 genetic quality tests on GMP-compliant human leucocyte antigen (HLA)-homozygous hiPSCs and their deri

70 disease (GVHD) after non-myeloablative human leucocyte antigen (HLA)-matched, unrelated donor, alloge

71 e conformational landscapes of peptide/human leucocyte antigen (pHLA) protein complexes encompassing

72 protein 2 (LMP2), in association with human leucocyte antigen A24, to treat therapy-refractory Epste

73 ing clinical features, IgG subclasses, human leucocyte antigen and CSF proteomic profiles.

74 ation, and de novo donor-specific anti-human leucocyte antigen antibodies (dnDSAs) have been associat

75 Human leucocyte antigen B*27 (HLA-B*27) is strongly associated

76 Human leucocyte antigen class I (HLA-I) molecules play a centr

77 s with the DRB1 and DQB alleles of the human leucocyte antigen class II region.

78 ocompatibility complex II (MHC II), or swine leucocyte antigen complex II (SLA II).

79 DC dysfunction, characterized by lower human leucocyte antigen DR expression and reduced interleukin

80 are relevant to susceptibility due to human leucocyte antigen expression and smoking.

81 ce of the role of environmental and nonhuman leucocyte antigen genetic factors in coeliac disease.

82 Multiple gene polymorphisms and human leucocyte antigen haplotype associations with primary sc

83 isms and ulcerative colitis associated human leucocyte antigen haplotypes are not associated with pri

84 dverse drug reactions (cADRs), such as human leucocyte antigen HLA-B*15:02, HLA-A*31:01 variants.

85 eceptor (TCR) and peptide presented by human leucocyte antigen molecule is a highly challenging task

86 ed association signals at 1q44 and the human leucocyte antigen region on chromosome 6.

87 We immunized human leucocyte antigen-A2 (HLA-A2) transgenic mice with an ad

88 which was indirectly supported by the human leucocyte antigen-Cw6 disease association.

89 1 psoriasis is strongly linked to the human leucocyte antigen-Cw6, recent genetic studies have sugge

90 We measured T-cell expression of Human Leucocyte Antigen-DR Isotype (HLA-DR), programmed death-

91 Human leucocyte antigen-G (HLA-G) is a non-classical HLA class

92 urvivals of 65-75% are achievable with human leucocyte antigen-matched related and unrelated donors.

93 ed with comparable survival to that of human leucocyte antigen-matched URD transplantation in childre

94 nd resistance are associated with both human leucocyte antigen-related and unrelated genetic factors.

95 ptors that recognize aberrantly folded human leucocyte antigen.

96 atients with circulating antibodies to human leucocyte antigens (anti-HLA) are highly sensitised agai

97 t their differentiated progeny express human leucocyte antigens (HLAs) that will probably cause graft

98 aving potential fusion neoantigens and human leucocyte antigens (HLAs), fusion breakpoint RNA/protein

99 nd no increase in the frequency of the human leucocyte antigens associated with narcolepsy.

100 ibutable to variants in genes encoding human leucocyte antigens, only about a quarter of reported her

101 While endothelial cells and leucocytes are widely accepted as critical players in th

102 ation can promote heart failure, positioning leucocytes as central protagonists and potential therape

103 hronic lymphocytic leukaemia cell per 10 000 leucocytes as measured by four-colour flow cytometry), a

104 immunoglobulin-like receptor B1 (LILRB1) or leucocyte-associated immunoglobulin-like receptor 1 (LAI

105 Both short and long leucocyte average telomere lengths (aTL) are associated

106 cluding the white matter tracts, with CXCR3+ leucocytes being the main contributor.

107 Enhanced leucocyte binding by HIMEC from chronically inflamed tis

108 We investigated whether this enhanced leucocyte binding is a primary or an acquired defect.

109 ammatory bowel disease--display an increased leucocyte-binding capacity in vitro.

110 riant in the mother was assessed in DNA from leucocytes, buccal cells and hair follicles using target

111 ced pleurisy, dominated by polymorphonuclear leucocytes, but may aid resolution at the later, mononuc

112 xpression could readily be detected in blood leucocytes by PCR analysis in all control samples but no

113 Techniques involving radiolabelled leucocytes can pinpoint the site of inflammation.

114 CD45, the leucocyte common antigen, is a haemopoietic cell-specifi

115 The leucocyte common antigen-related receptor tyrosine phosp

116 clock, GrimAge, and PhenoAge) and estimated leucocyte compositions were generated using Horvath's Ne

117 fied variables (initial nonShockable rhythm, Leucocyte count < 4 or > 12 K/muL after targeted tempera

118 ory of heart failure (OR, 1.43 [1.01-2.03]), leucocyte count </=72 hours after TAVI (OR, 1.05 [1.02-1

119 s 158 [25%] in the control group), decreased leucocyte count (103 [16%] vs 74 [20%]), fatigue (81 [13

120 5% CI 11.3 to 28.8; p<0.0001), increased CSF leucocyte count (2.01 per 5 cells per muL, 1.61 to 2.39;

121 an trypanosomiasis and a cerebrospinal fluid leucocyte count less than 100 per muL.

122 arlson comorbidity index, haemoglobin count, leucocyte count, creatinine levels, cause of perforation

123 ate analysis, means of parameters like total leucocyte count, urea, bilirubin, alanine transaminase,

124 l criteria among fever, CRP serum level, and leucocytes count).

125 -response markers in serum and sputum, blood leucocyte counts and serum inflammatory cytokines.

126 is suggested a 6.3% to 11.5% contribution of leucocyte counts in the association of blood Cd and Pb l

127 iodontal therapy on arterial blood pressure, leucocyte counts, fibrinogen, tissue necrosis factor-a,

128 esulted in increased migration/activation of leucocytes crossing the 22qDS+schizophrenia blood-brain

129 recombinant IL-1beta in primary head kidney leucocyte cultures and RTS-11 cells, a macrophage cell l

130 iation of cysteamine therapy and higher mean leucocyte cystine levels.

131 The gram stain and acridine-orange leucocyte cytospin test (AOLC) is rapid (30 min), inexpe

132 transcriptomic analysis of peripheral blood leucocytes defines two distinct sepsis response signatur

133 Here, we show in humans and mice that leucocytes deplete rapidly from the blood after a single

134 Leucocyte depletion studies confirmed that this differen

135 Here we show that the packaging of mRNA into leucocyte-derived EVs and the endocytosis of the EVs by

136 Although leucocyte-derived extracellular vesicles (EVs) can cross

137 cteria tuberculosis chaperonin 60.1 inhibits leucocyte diapedesis and bronchial hyperresponsiveness i

138 n interferon signalling (IL10RB and PLSCR1), leucocyte differentiation (BCL11A) and blood-type antige

139 5-mC content was measured in leucocyte DNA by use of a combination of high-performanc

140 th was calculated by in-gel hybridisation to leucocyte DNA from 56 normal individuals aged 0-96 years

141 %5-mC was measured in leucocyte DNA from 775 cases and 397 controls.

142 leucocyte DNA were detected, we also tested leucocyte DNA from the individuals' fathers, and in one

143 ave shown in a large case-control study that leucocyte DNA hypomethylation is associated with increas

144 er mL, we detected Y-chromosome deletions in leucocyte DNA similar in location to those previously re

145 he two men in whom Y-chromosome deletions in leucocyte DNA were detected, we also tested leucocyte DN

146 By PCR, we tested leucocyte DNA, from 35 men who presented at infertility

147 Screening this library for binding to human leucocyte elastase identified sequences with a strong co

148 Human leucocyte elastase is known to have a substrate preferen

149 Testing of the human leucocyte elastase-selected sequences as inhibitors of p

150 helial damage, innate immune activation, and leucocyte-endothelial interactions in the pathology of s

151 isozymes in monocytes and polymorphonuclear leucocytes ex vivo.

152 Anx-1-/- polymorphonuclear leucocytes exhibited increased spontaneous migratory beh

153 mental stress rapidly amplifies inflammatory leucocyte expansion inside mouse atherosclerotic lesions

154 When selected growth factors were added, leucocytes expressing CD45 were generated and released i

155 Leucocyte expressions of mRNA TLR2, TLR4, TNF-a, IL1B, I

156 olysate (Colagenart), and a human dialyzable leucocyte extract (Transferon).

157 In 7 DCD livers, a leucocyte filter was added to the circuit during perfusi

158 undamental role in the tissue recruitment of leucocytes following exposure to allergens.

159 0 expression in human cell lines and primary leucocytes following treatment with rhinovirus.

160 Leucocytes found in the healthy heart participate in ess

161 Deconvolution of leucocyte fractions was conducted.

162 that the RNA sequences in high abundance in leucocytes from chronic granulocytic leukaemias differ q

163 then serve as mechanical anchors to capture leucocytes from the blood stream.

164 osure leads to prompt uptake of inflammatory leucocytes from the blood to distinct tissues including

165 dysfunction and leucocyte adhesion, whereas leucocytes from these mice did not show altered adhesive

166 cells, the interaction of the beta2 integrin leucocyte function-associated antigen-1 (LFA-1) with its

167 and thus evaluated the relationship of blood leucocyte gene expression to progression of cerebral whi

168 yperintensity volumes over time and baseline leucocyte gene expression was analysed.

169 We assayed peripheral blood leucocyte global gene expression for a prospective disco

170 ing genetic variants at specific loci, human leucocyte (HLA) haplotypes, or the blood innate immune r

171 Comparison between 99mTc Infecton and leucocyte imaging gave sensitivities of 84% and 81%, and

172 ound that a subset of RIFINs binds to either leucocyte immunoglobulin-like receptor B1 (LILRB1) or le

173 by lipopolysaccharide (LPS) stimulated human leucocytes in order to provide an initial structure-acti

174 f up to about 3000 compared to the number of leucocytes in the blood.

175 le mice exhibit a reduction in the number of leucocytes in the lung lumen when challenged with OVA an

176 at form virological synapses with uninfected leucocytes in the lymph node of living mice.

177 Specifically, OSM, expressed by CD45(+) leucocytes in the stromal vascular fraction, induced pho

178 endritic cells (DCs), recruited inflammatory leucocytes, including APCs in mice, and promoted antigen

179 arge vessel disease that is characterized by leucocyte infiltration and lipid deposition in the wall

180 y injury SEMA3C promotes interstitial edema, leucocyte infiltration and tubular injury.

181 e disease in MRL-lpr mice is associated with leucocyte infiltration into the choroid plexus, brain ce

182 Leucocyte infiltration with vascular leakage and express

183 promoting matrix destruction, angiogenesis, leucocyte infiltration, and apoptosis.

184 iated with a marked reduction in ICH-induced leucocyte infiltration, microglia/macrophage activation

185 VS tumours are characterised by extensive leucocyte infiltration.

186 negative breast cancer (TNBC) often exhibits leucocyte infiltrations that correlate with favorable pr

187 sion of proinflammatory molecules, decreased leucocyte inflammation, and significantly improved graft

188 tically, we found that acute stress enhances leucocyte influx into mouse atherosclerotic plaques by m

189 le-1 (ICAM-1) functions via its ligands, the leucocyte integrins, in adhesion of immune cells to endo

190 ytokines seem able to attract HIV-1-infected leucocytes into the amniotic cavity and to increase repl

191 by the migration of HIV-1-infected maternal leucocytes into the amniotic cavity.

192 se interaction between endothelial cells and leucocytes is a key regulatory step in the inflammatory

193 Swift recruitment of phagocytic leucocytes is critical in preventing infection when bact

194 n regulates responses by respiratory mucosal leucocytes isolated from nasal polyps.

195 Leucocyte (L)-selectin is essential for mounting protect

196 icating genes involved in the 'regulation of leucocyte/lymphocyte activity' and also 'cytokine-mediat

197 mapping nanoparticle-mediated complement and leucocyte/macrophage responses.

198 esis-characterized by significantly elevated leucocyte (mainly neutrophil and monocytes) and erythroc

199 iological turnover of erythrocytes and other leucocytes, making it the most abundant form of cell dea

200 active oxygen species from polymorphonuclear leucocytes may be potential inducers of the RprY regulon

201 s or lysis by complement or by IgG-dependent leucocyte mediators.

202 te airway smooth muscle cell contraction and leucocyte migration and proliferation.

203 and BtSULT homologues in bacteria inhibited leucocyte migration in vitro and in vivo, and abundances

204 ephrine signalling diminished stress-induced leucocyte migration into mouse atherosclerotic plaques.

205 In conclusion peripheral leucocyte molecular indicators of inflammation and plasm

206 The leucocyte mRNA expressions of TLR2, TLR4, STAT 3, IL1B,

207 Significant increases in leucocyte, neutrophil, eosinophil, basophil and monocyte

208 C-030031 treatment also dramatically reduced leucocyte numbers and IL-8 level in the BAL fluid, inhib

209 tic-like response: bronchial-alveolar lavage leucocyte numbers, Muc5ac and Muc5b mRNA levels, and Cla

210 OAT mRNA was isolated from peripheral blood leucocytes of 1 patient and analyzed.

211 to distinguish clearly the peripheral blood leucocytes of chronic granulocytic leukaemias from other

212 ther the GCase activity level was altered in leucocytes of these subjects and how it was related to d

213 g a sensitive KIT mutation analysis of blood leucocytes or measurement of urinary histamine metabolit

214 genome-wide studies in ARDS use total blood leucocytes; our study is the first, to our knowledge, to

215 ecreased FMRP expression in peripheral blood leucocytes over the same repeat range, despite a slight

216 ion has been noted in human peripheral blood leucocytes (PBL).

217 py remains recommended for patients with 100 leucocytes per muL or more.

218 -documented impairments in polymorphonuclear leucocyte (PMN) function.

219 Granulocyte [polymorphonuclear leucocyte (PMN)] migration to sites of infection and sub

220 CMV pp65 antigen positive polymorphonuclear leucocytes (PMNLs) per 200 000 cells previously reported

221 we demonstrated that blood polymorphonuclear leucocytes (PMNs) in ARDS are basally activated, and exh

222 mRNA from human polymorphonuclear neutrophil leucocytes (PMNs) was probed with cDNA encoding human sk

223 aired defense functions of polymorphonuclear leucocytes (PMNs), increased patient susceptibility to i

224 Hepatic leucocyte populations and their cytokine/chemokine produ

225 d RNAs of a variety of normal and neoplastic leucocyte populations showed that the RNA sequences in h

226 To compare peripheral blood leucocyte populations using flow cytometry at baseline a

227 epresenting the RNAs of normal and leukaemic leucocyte populations were sufficiently different to dis

228 before and after treatment, and in purified leucocyte populations.

229 including the presence of symptoms, urinary leucocytes, positive urine culture and symptom resolutio

230 pithelial barrier and may then interact with leucocytes, potentially inducing proinflammatory respons

231 or their ability to inhibit murine and human leucocyte proliferation and TNF-alpha secretion by lipop

232 Secretory leucocyte protease inhibitor (SLPI) is a 107-amino acid

233 clude PLC-gamma2, Syk, SH2-domain-containing leucocyte protein of 76 kDa (SLP-76), Lyn, linker for ac

234 NE and Cat G selective inhibitor, secretory leucocyte proteinase inhibitor, reduction of the enhance

235 hide core domain proteins, such as secretory leucocyte proteinase-1 (SLP-1), but the Trichuris protei

236 We used the mixed leucocyte reaction (MLR), stimulating one partner's peri

237 ed CD8(+) T-cell-mediated killing in a mixed leucocyte reaction.

238 tor cells), cytochemical staining, and mixed leucocyte reactions to determine the functional capacity

239 gnaling from inflammatory PT cells mediating leucocyte recruitment and myofibroblast activation.

240 lung inflammation through a dual function in leucocyte recruitment and tissue remodelling and may rep

241 Here we describe a more rapid mechanism of leucocyte recruitment to the site of intrusion of the im

242 As well as regulating leucocyte recruitment, it also regulates their activatio

243 novirus-induced ORMDL3 expression in primary leucocytes required cell-cell contact, and induction was

244 These hES-derived, MHC class II+ leucocytes resembled dendritic cells and macrophages, an

245 ing eosinophil counts of 2% or more of blood leucocytes respond better to inhaled corticosteroids tha

246 uantum yield (approximately 0.98), and human leucocyte-specific monoclonal antibodies (CD3, CD4, and

247 ese patients with those from a radiolabelled leucocyte study.

248 Secondary outcomes were leucocyte subpopulation counts, serum immunoglobulin lev

249 ich could favour the recruitment of distinct leucocyte subsets into the skin.

250 egulation of DNA methylation-based estimated leucocyte subsets towards more differentiated T-cell phe

251 ity lipoprotein, and the counts of different leucocyte subsets.

252 roscopy and flow cytometry of graft-specific leucocyte surface marker CD45 and macrophage marker CD68

253 Leucocyte telomere length (LTL) shortening is associated

254 Leucocyte telomere length and gene expression related to

255 hazard ratio; 95% CI 1.27 for a doubling of leucocyte telomere length at baseline; 1.05-1.44] than p

256 Mean leucocyte telomere length is a predictor of future coron

257 Our aim was to determine whether mean leucocyte telomere length is a predictor of the developm

258 are modified by biological age (assessed by leucocyte telomere length: LTL).

259 Shorter leucocyte telomere lengths are associated with worse sur

260 estigate whether patients with various blood leucocyte telomere lengths had different overall surviva

261 Eosinophils are immunomodulatory leucocytes that contribute to the pathogenesis of Th2-dr

262 muscle use can stimulate muscle invasion by leucocytes that have the potential to increase tissue da

263 latelets and other cells (endothelial cells, leucocytes) that contribute to an inflammatory response,

264 o-immunized with their partners' mononuclear leucocytes to prevent spontaneous recurrent abortion.

265 Vs by neurons can be enhanced by engineering leucocytes to produce EVs that incorporate retrovirus-li

266 d capillary blood flow caused by adhesion of leucocytes to the brain microvascular endothelium leads

267 AM-1 mediates adhesion and transmigration of leucocytes to the vascular endothelial wall, a step prop

268 remission dynamics of MS in peripheral blood leucocytes, to shed light on the molecular and regulator

269 g events play additional functional roles in leucocyte trafficking.

270 mutant resulted in reduced polymorphonuclear leucocyte transepithelial migration and mitogen-activate

271 rotein kinase pathways and polymorphonuclear leucocyte transepithelial migration associated with Shig

272 ORMDL3, HSPA5 and IFNB1 expression varied by leucocyte type and 17q21 genotype, with the highest expr

273 Anaplastic lymphoma kinase (Alk) and leucocyte tyrosine kinase (Ltk) were identified as "orph

274 of the activity of the sodium pump of human leucocytes was used to test each fraction for the presen

275 ease negativity (cutoff 4 x 10-5 bone marrow leucocytes) was achieved in 55% of patients tested in th

276 s from MFD-1, tumour, normal oesophagus, and leucocytes were analysed with SNP6.

277 erived from endothelial cells, monocytes and leucocytes were at concentrations similar to baseline in

278 ukin 1 and cytokine mRNA in peripheral-blood leucocytes were not raised, but amounts of interleukin 1

279 inoma patients' peripheral blood mononuclear leucocytes were stimulated in vitro with autologous tumo

280 inant cells at 2 hours are polymorphonuclear leucocytes, whereas mononuclear cells dominate from 24 h

281 , followed by tissue destruction mediated by leucocytes which clinically cause significant destructio

282 tiated T-cell phenotypes and proinflammatory leucocytes, which was also partly restored with ART.

283 immortalized and primary bone-marrow-derived leucocytes with DNA or RNA encoding the capsid-forming a

284 lated by stimulation of isolated head kidney leucocytes with lipopolysaccharide (LPS).

285 also induced following stimulation of kidney leucocytes with lipopolysaccharide for 4 h.